Gilead Sciences Inc是一家生物制药公司。该公司专注于预防和治疗人类免疫缺陷病毒(HIV)、病毒性肝炎和癌症等疾病的药物的发现、开发和商业化。该公司针对HIV/AIDS患者的产品包括 Biktarvy、Genvoya、Descovy、Odefsey、Truvada、Complera/...查看更多 最新报告2024年11月6日 下一期财报2025年2月11日 连续10年上调股息...
Price Estimate# EstimatesHighMeanLow# Estimates3 Week2 Week1 WeekCurrent030609012015025.52626.52727.528 Current1 Week Ago2 Weeks Ago3 Weeks Ago High Target Price Estimate 125.00 125.00 125.00 125.00 Low Target Price Estimate 80.00 73.00 73.00 73.00 Mean Target Price Estimate 101.00 99.78 100.08 100.08...
USDNasdaq Global SelectDelayed PriceMarket Closed Earnings High Target Price 125.00 Mean Target Price 101.00 Low Target Price 80.00 Standard Deviation: 12.82 Number of Estimates 26 Date of Most Recent Estimate 02/12/25 Price Estimate# EstimatesHighMeanLow# Estimates3 Week2 Week1 WeekCurrent030609012015...
GILD Stock Price 1D 5D 1M 6M YTD 1Y 5Y 10Y MAX Basic Advanced +42.50% Gilead Sciences, Inc. price and volume Combination chart with 2 data series. Chart represents Gilead Sciences, Inc. price and volume over 1Y period The chart has 2 X axes displaying Time, and Time. The chart has ...
Dec-16-24 12:00PM Gilead (GILD) Upgraded to Buy: Here's Why (Zacks) Dec-13-24 05:50PM Gilead Sciences (GILD) Stock Moves -0.57%: What You Should Know (Zacks) 12:15PM Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report (Benzinga) 06:37AM Gilead's Selade...
Analyst Price Target is $98.39 ▲ +2.45% Upside Potential This price target is based on 27 analysts offering 12 month price targets for Gilead Sciences in the last 3 months. The average price target is $98.39, with a high forecast of $125.00 and a low forecast of $69.00. The average ...
Gilead Sciences IncGILD:NASDAQ RT Quote|Last NASDAQ LS, VOL From CTA|USD After Hours:Last |01/31/25 EST 96.70-0.50(-0.51%) Volume 629,686 Close 97.20+0.25(+0.26%) Volume 8,785,020 52 week range 62.07-98.90 SummaryNewsProfileEarningsPeersFinancialsOptionsOwnership ...
Average Price Target $99.29 ▲(8.34% Upside) Based on 26 Wall Street analysts offering 12 month price targets for Gilead Sciences in the last 3 months. The average price target is $99.29 with a high forecast of $125.00 and a low forecast of $73.00. The average price target represents a ...
GILD - Gilead Sciences Inc. Chart, Quote and financial news from the leading provider and award-winning BigCharts.com.
Skip NavigationMarkets Business Investing Tech Politics Video Investing Club